[Chemotherapy of malignant brain tumor by a water-soluble anti-tumor nitrosourea, ACNU (author's transl)].
[Chemotherapy of malignant brain tumor by a water-soluble anti-tumor nitrosourea, ACNU (author's transl)].
复制标题
[水溶性抗肿瘤亚硝基脲,ACNU(作者翻译)对恶性脑肿瘤的化疗]。
DOI:
10.2176/nmc.19.1157
复制
发表时间:
1979
影响因子:
1.9
通讯作者:
R. Katakura
中科院分区:
文献类型:
--
作者:
Teruaki Mori;K. Mineura;R. Katakura
For the purpose of treatment of brain tumors with ACNU [1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride], inhibitory effects on tumor cell proliferation in vitro, pharmacokinetics, clinical responses and side effects of the drug were investigated. ED50 of ACNU for KS-1 cells was 25 μg/ml. Generally, glioblastoma cells were more sensitive to ACNU than meningioma cells. After intravenous injection of ACNU 100-150 mg/boby, in 14 patients with brain tumors, transition of the drug into cerebrospinal fluid was noticed at 5 minutes in all cases with the maximum value of 0.59±0.13 μg/ml at 30 minutes. The therapeutic effects of the drug were evaluated in 31 patients with brain tumors by neurological and CT-scan examinations. Combined chemo-radiotherapy with ACNU, FT207 and Tele-cobalt was more effective than ACNU therapy alone; 36% of the patients were “improved” in our criteria, although hematologic toxicity of ACNU was observed in 55%.